Thomas Frist Jr., MD, $17 billion, founded Hospital Corp. of America in 1968.
Carl Cook, $9.7 billion, is CEO of medical device manufacturer Cook Group.
Reinhold Schmieding, $6.5 billion, started orthopedic surgical tools company Arthrex in 1981 and still owns more than 90 percent of the company.
Ge Li, $6.1 billion, co-founded WuXi AppTec.
Patrick Soon-Shiong, MD, $5.7 billion, was a practicing physician before inventing the cancer medication Abraxane.
Ronda Stryker, $5.6 billion, is a director of medical equipment company Stryker Corp.
John Brown, $4.5 billion, ran Stryker Corp. for 32 years.
Jon Stryker, $3.5 billion, inherited a stake in Stryker Corp.
Stewart Rahr, $2.8 billion, expanded his father’s pharmaceutical company Kinray.
Pat Stryker, $2.7 billion, inherited a stake in Stryker Corp.
Leonard Schleifer, $2.5 billion, co-founded and remains CEO of drugmaker Regeneron.
Osman Kibar, $2.3 billion, is the founder and CEO of San Diego-based biotech firm Samumed.
Hao Hong, $2.1 billion, is the chairman of pharmaceutical outsourcing company Asymchem Laboratories.
Alice Schwartz, $2 billion, launched lab research facilitator Bio-Rad in 1952.
Amy Wyss, $1.8 billion, worked at medical equipment firm Synthes for years before it sold to Johnson & Johnson.
Phillip Frost, $1.8 billion, runs diagnostic-maker Opko Health.
Timothy Springer, $1.8 billion, was a founding investor in Moderna and works as a professor of biochemistry at Boston-based Harvard Medical Center.
Gary Michelson, MD, $1.8 billion, is a retired orthopedic and spine surgeon who holds over 340 U.S. patents.
James Leininger, MD, $1.7 billion, founded medical device company Kinetic Concepts.
Keith Dunleavy, MD, $1.7 billion, is the founder of cloud-based data analytics company Inovalon.
Randal Kirk, $1.7 billion, is a chairman of private equity firm Third Security, and the former CEO of biotech firm Precigen.
Robert Duggan, $1.6 billion, led the 2015 sale of biotech firm Pharmacyclics to AbbVie.
George Yancopoulos, MD, $1.6 billion, is the chief scientific officer at biotech firm Regeneron.
David Paul, $1.6 billion, is the founder and executive chairman of spine manufacturer Globus Medical.
Jeff Tangney, $1.5 billion, co-founded Doximity.
August Troendle, MD, $1.5 billion, is the president and CEO of clinical research company Medpace.
Noubar Afeyan, $1.4 billion, is the founder and CEO of life sciences innovation firm Flagship Pioneering.
Robert Langer, MD, $1.4 billion, is a scientist and professor at the Massachusetts Institute of Technology (Cambridge) and a co-founder of Moderna.
Joe Kiani, $1.1 billion, runs medical technology firm Masimo Corp.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.